Chemokines Induce Wnt-Frizzled Gene Expression in Human T Cells

趋化因子诱导人类 T 细胞中 Wnt 卷曲基因表达

基本信息

  • 批准号:
    7592056
  • 负责人:
  • 金额:
    $ 23.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Chemokines have been shown to induce and direct adhesion, chemotaxis, activation, and degranulation of human and rodent leukocytes both in vitro and in vivo. CXCL12 and CCL19 are two important chemokines that regulate T cell motility and activation under normal and inflammatory conditions. Despite numerous reports examining the function of chemokines, little is known about the molecular changes induced by these ligands. We have identified by microarray analysis differentially expressed genes in human T cells following treatment with CXCL12 or CCL19. In primary T cells, it was observed that the genes associated with non canonical Wnt signaling pathway are significantly induced by chemokines compared to vehicle control-treated cells. The non-canonical Wnts, Wnt5a and Wnt10a, along with their receptors Fzd2 and Fzd3 were significantly induced upon CXCL12 and CCL19 treatment, respectively, in a time-dependent fashion. The up regulation of these genes was confirmed by real time PCR and western blot analysis. In addition, the transcriptional activation of both Wnt5a and Wnt10a promoter by CXCL12 and CCL19 was further confirmed by electrophoretic mobility shift assay (EMSA). siRNA and shRNA knockdown of Wnt5a in primary T cells and transformed T cell lines, respectively, significantly inhibited CXCR4 and CCR7 signaling and function suggesting an important intermediary role for the Wnt-Fzd pathways in chemokine-chemokine receptor function. Moreover, these chemokine-induced Wnt and Fzd molecules appear to play a critical role in PKC and Rac activation, MMP expression and actin polymerization in response to chemokine stimulation. Similar effects were observed using melanoma cell lines. In vivo studies are currently underway to support the function role of this pathway in lymphocyte migration and trafficking. Together, these results provide insight into chemokine-induced gene activation and implicate the possible involvement of the non-canonical Wnt signaling pathway in chemokine activation and T cell trafficking. Moreover, we are also currently verifying and characterizing several additional gene families that are highly expressed in T cells after migration in response to or simply stimulation with CXCL12, CCL19, gp120 and HIV-1 virus. Moreover, the role of lipid rafts in chemokine biology and HIV infectivity are also under examination using microarray analysis. A greater understanding of the transcriptional signals differentially induced by the ligation of various chemokine receptors may provide a means to dissect the pathways by which these chemoattractants induce cell migration and activation as well as any host transcriptional signals important in HIV entry and replication.
趋化因子已被证明在体外和体内诱导和指导人和啮齿动物白细胞的粘附、趋化、活化和脱粒。CXCL 12和CCL 19是两种重要的趋化因子,在正常和炎症条件下调节T细胞运动和活化。尽管有许多研究趋化因子功能的报道,但对这些配体诱导的分子变化知之甚少。我们已经通过微阵列分析鉴定了用CXCL 12或CCL 19处理后人类T细胞中差异表达的基因。在原代T细胞中,观察到与媒介物对照处理的细胞相比,与非经典Wnt信号传导途径相关的基因被趋化因子显著诱导。在CXCL 12和CCL 19处理后,非典型Wnt,Wnt 5a和Wnt 10a,沿着其受体Fzd 2和Fzd 3分别以时间依赖性方式显著诱导。 通过真实的时间PCR和蛋白质印迹分析证实这些基因的上调。此外,通过电泳迁移率变动分析(EMSA)进一步证实了CXCL 12和CCL 19对Wnt 5a和Wnt 10a启动子的转录激活。在原代T细胞和转化T细胞系中Wnt 5a的siRNA和shRNA敲低分别显著抑制CXCR 4和CCR 7信号传导和功能,表明Wnt-Fzd途径在趋化因子-趋化因子受体功能中的重要中介作用。此外,这些趋化因子诱导的Wnt和Fzd分子似乎在响应于趋化因子刺激的PKC和Rac活化、MMP表达和肌动蛋白聚合中起关键作用。 使用黑色素瘤细胞系观察到类似的效果。 目前正在进行体内研究,以支持该途径在淋巴细胞迁移和运输中的功能作用。总之,这些结果提供了深入了解趋化因子诱导的基因激活,并暗示可能参与的非经典Wnt信号通路在趋化因子激活和T细胞运输。 此外,我们目前还在验证和表征几个额外的基因家族,这些基因家族在迁移后在T细胞中高度表达,以响应或简单地刺激CXCL 12,CCL 19,gp 120和HIV-1病毒。此外,脂筏在趋化因子生物学和HIV感染性中的作用也正在使用微阵列分析进行检查。 更好地了解不同的转录信号诱导的各种趋化因子受体的连接可能提供一种手段来解剖这些化学引诱剂诱导细胞迁移和激活的途径,以及任何主机的转录信号在HIV的进入和复制的重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENNIS D. TAUB其他文献

DENNIS D. TAUB的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENNIS D. TAUB', 18)}}的其他基金

Phenotypic And Functional Changes In Circulating T Cells
循环 T 细胞的表型和功能变化
  • 批准号:
    6530497
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:
Thymic Involution And Age-associated Changes In T Cells
T 细胞的胸腺退化和年龄相关变化
  • 批准号:
    6530518
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:
Homocysteine Stimulates Human T Cell Effector Cell
同型半胱氨酸刺激人类 T 细胞效应细胞
  • 批准号:
    6530501
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:
Immunoregulatory and Adjuvant effects of Hormones on the
激素对免疫调节和辅助作用
  • 批准号:
    6674114
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:
Mechanisms that Regulate Thymic Involution and Age-Assoc
调节胸腺复旧和年龄相关的机制
  • 批准号:
    6674124
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:
Gene Expression Induced by HIV-1 and Chemokine Receptor
HIV-1 和趋化因子受体诱导的基因表达
  • 批准号:
    6969410
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:
Mechanisms that Regulate Thymic Involution and Age-Assoc
调节胸腺复旧和年龄相关的机制
  • 批准号:
    6969413
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:
Homocysteine Stimulates T Cell Activation, Apoptosis and Thymic Involution
同型半胱氨酸刺激 T 细胞激活、凋亡和胸腺复旧
  • 批准号:
    8552469
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:
Characterization of Immune Alterations Associated with the Aging Process
与衰老过程相关的免疫改变的特征
  • 批准号:
    8552317
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:
HIV Pathogenesis: Differential Effects on Lymphocyte Sub
HIV 发病机制:对淋巴细胞亚群的不同影响
  • 批准号:
    7324968
  • 财政年份:
  • 资助金额:
    $ 23.06万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 23.06万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 23.06万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 23.06万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 23.06万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 23.06万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 23.06万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 23.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了